The long noncoding RNA Wisper controls cardiac fibrosis and remodeling
暂无分享,去创建一个
Richard A Young | Samir Ounzain | Blanche Schroen | R. Young | B. Schroen | B. Abraham | R. Micheletti | M. Alexanian | M. Nemir | A. Sarre | T. Pedrazzini | Arantxa González | I. Plaisance | Arantxa González | Rudi Micheletti | Isabelle Plaisance | Brian J Abraham | Alexandre Sarre | Ching-Chia Ting | Michael Alexanian | Daniel Maric | Damien Maison | Mohamed Nemir | Thierry Pedrazzini | Damien Maison | S. Ounzain | D. Maric | Ching-Chia Ting | R. Young | Michael Alexanian
[1] L. Pennacchio,et al. Functional importance of cardiac enhancer-associated noncoding RNAs in heart development and disease , 2014, Journal of molecular and cellular cardiology.
[2] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[3] P. Zhang,et al. A Long Non-Coding RNA Defines an Epigenetic Checkpoint in Cardiac Hypertrophy , 2016 .
[4] S. Dimmeler,et al. MicroRNAs in myocardial infarction , 2015, Nature Reviews Cardiology.
[5] Thomas Thum,et al. Non-coding RNAs in cardiac remodeling and heart failure. , 2013, Circulation research.
[6] N. Hannett,et al. Transcription factor trapping by RNA in gene regulatory elements , 2015, Science.
[7] J. M. Izquierdo,et al. T-cell intracellular antigens in health and disease , 2015, Cell cycle.
[8] S. Simpson. Of Mice . . . , 2004, Science.
[9] K. Morris,et al. The rise of regulatory RNA , 2014, Nature Reviews Genetics.
[10] 中山 幸輝. A long noncoding RNA protects the heart from pathological hypertrophy , 2015 .
[11] D. Reinhardt,et al. Functional diversity of lysyl hydroxylase 2 in collagen synthesis of human dermal fibroblasts. , 2006, Experimental cell research.
[12] B. Schroen,et al. microRNA-122 down-regulation may play a role in severe myocardial fibrosis in human aortic stenosis through TGF-β1 up-regulation. , 2014, Clinical science.
[13] N. Frangogiannis,et al. The inflammatory response in myocardial injury, repair, and remodelling , 2014, Nature Reviews Cardiology.
[14] Manuel D. Díaz-Muñoz,et al. Generation of functionally distinct isoforms of PTBP3 by alternative splicing and translation initiation , 2015, Nucleic acids research.
[15] R. Bonow,et al. Therapeutic targets in heart failure: refocusing on the myocardial interstitium. , 2014, Journal of the American College of Cardiology.
[16] S. Pfeffer,et al. Identification of factors involved in target RNA-directed microRNA degradation , 2016, Nucleic acids research.
[17] Véronique Kruys,et al. Identification of the sequence determinants mediating the nucleo-cytoplasmic shuttling of TIAR and TIA-1 RNA-binding proteins , 2005 .
[18] L. Boyer,et al. Lncing epigenetic control of transcription to cardiovascular development and disease. , 2015, Circulation research.
[19] M. Entman,et al. Myocardial ischemia and reperfusion: a murine model. , 1995, The American journal of physiology.
[20] G. Lemesle,et al. The Circulating Long Non-Coding RNA LIPCAR Predicts Survival in Heart Failure Patients , 2014 .
[21] M. Garcia-Blanco,et al. TIA nuclear proteins regulate the alternate splicing of lysyl hydroxylase 2. , 2009, The Journal of investigative dermatology.
[22] F. Liu,et al. The Long Noncoding RNA CHRF Regulates Cardiac Hypertrophy by Targeting miR-489 , 2014, Circulation research.
[23] Maria-Teresa Piccoli,et al. Non-coding RNAs as modulators of the cardiac fibroblast phenotype. , 2016, Journal of molecular and cellular cardiology.
[24] A. Ladd,et al. Diversity and conservation of CELF1 and CELF2 RNA and protein expression patterns during embryonic development , 2013, Developmental dynamics : an official publication of the American Association of Anatomists.
[25] Zicai Liang,et al. MALAT‐1 interacts with hnRNP C in cell cycle regulation , 2013, FEBS letters.
[26] R. Guigó,et al. CARMEN, a human super enhancer-associated long noncoding RNA controlling cardiac specification, differentiation and homeostasis. , 2015, Journal of molecular and cellular cardiology.
[27] M. Zile,et al. Integrating the myocardial matrix into heart failure recognition and management. , 2013, Circulation research.
[28] L. Mazzolai,et al. Two-kidney, one clip and one-kidney, one clip hypertension in mice. , 1997, Hypertension.
[29] R. Young,et al. Super-Enhancers in the Control of Cell Identity and Disease , 2013, Cell.
[30] Paul Theodor Pyl,et al. HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.
[31] Ivan C. Gerling,et al. Myofibroblast-mediated mechanisms of pathological remodelling of the heart , 2013, Nature Reviews Cardiology.
[32] Runsheng Chen,et al. LncRNA MT1JP functions as a tumor suppressor by interacting with TIAR to modulate the p53 pathway , 2016, Oncotarget.
[33] Samir Ounzain,et al. The promise of enhancer-associated long noncoding RNAs in cardiac regeneration. , 2015, Trends in cardiovascular medicine.
[34] E. Small,et al. Transcriptional control of cardiac fibroblast plasticity. , 2016, Journal of molecular and cellular cardiology.
[35] J. M. Izquierdo,et al. T-cell Intracellular Antigen (TIA)-Proteins Deficiency in Murine Embryonic Fibroblasts Alters Cell Cycle Progression and Induces Autophagy , 2013, PloS one.
[36] M. Rosenfeld,et al. Enhancers as non-coding RNA transcription units: recent insights and future perspectives , 2016, Nature Reviews Genetics.
[37] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[38] Mark D. Robinson,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..
[39] Wei Li,et al. RSeQC: quality control of RNA-seq experiments , 2012, Bioinform..
[40] G. Lemesle,et al. Circulating Long Noncoding RNA, LIPCAR, Predicts Survival in Patients With Heart Failure , 2014, Circulation research.
[41] David A. Orlando,et al. Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes , 2013, Cell.
[42] Matthew C.J. Wilce,et al. RNA Recognition and Stress Granule Formation by TIA Proteins , 2014, International journal of molecular sciences.
[43] Alexandro E. Trevino,et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex , 2014, Nature.
[44] J. Lieb,et al. What are super-enhancers? , 2014, Nature Genetics.
[45] Colin N. Dewey,et al. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.
[46] M. Swanson,et al. MBNL1-mediated regulation of differentiation RNAs promotes myofibroblast transformation and the fibrotic response , 2015, Nature Communications.
[47] J. Mattick,et al. Structure and function of long noncoding RNAs in epigenetic regulation , 2013, Nature Structural &Molecular Biology.
[48] N. Frangogiannis. Pathophysiology of Myocardial Infarction. , 2015, Comprehensive Physiology.
[49] T. Pedrazzini,et al. Super-enhancer lncs to cardiovascular development and disease. , 2016, Biochimica et biophysica acta.
[50] J. Kovacic,et al. Matricellular Protein CCN5 Reverses Established Cardiac Fibrosis. , 2016, Journal of the American College of Cardiology.
[51] Laurie A Boyer,et al. Distal enhancers: new insights into heart development and disease. , 2014, Trends in cell biology.
[52] S. Prabhu,et al. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. , 2016, Circulation research.
[53] R. Guigó,et al. Genome-wide profiling of the cardiac transcriptome after myocardial infarction identifies novel heart-specific long non-coding RNAs , 2014, European heart journal.
[54] B. Hogan,et al. Hyperactive Wnt signaling changes the developmental potential of embryonic lung endoderm , 2004, Journal of biology.
[55] J. Stévenin,et al. TIA-1 and TIAR Activate Splicing of Alternative Exons with Weak 5′ Splice Sites followed by a U-rich Stretch on Their Own Pre-mRNAs* , 2001, The Journal of Biological Chemistry.
[56] Michael Briese,et al. iCLIP Predicts the Dual Splicing Effects of TIA-RNA Interactions , 2010, PLoS biology.
[57] J. Rinn,et al. "Cat's Cradling" the 3D Genome by the Act of LncRNA Transcription. , 2016, Molecular cell.
[58] Albert E. Almada,et al. Divergent transcription of long noncoding RNA/mRNA gene pairs in embryonic stem cells , 2013, Proceedings of the National Academy of Sciences.
[59] E. Creemers,et al. Function and Therapeutic Potential of Noncoding RNAs in Cardiac Fibrosis. , 2016, Circulation research.
[60] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[61] Arantxa González,et al. Collagen Cross-Linking But Not Collagen Amount Associates With Elevated Filling Pressures in Hypertensive Patients With Stage C Heart Failure: Potential Role of Lysyl Oxidase , 2012, Hypertension.
[62] T. Mikkelsen,et al. The NIH Roadmap Epigenomics Mapping Consortium , 2010, Nature Biotechnology.
[63] Xing Li,et al. Quality control of RNA-seq experiments. , 2015, Methods in molecular biology.
[64] A. Schambach,et al. Long noncoding RNA Chast promotes cardiac remodeling , 2016, Science Translational Medicine.
[65] David R. Kelley,et al. Topological organization of multichromosomal regions by the long intergenic noncoding RNA Firre , 2014, Nature Structural &Molecular Biology.
[66] C. Long,et al. Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs. , 2014, Journal of molecular and cellular cardiology.
[67] Mark D. Huffman,et al. Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association , 2016, Circulation.
[68] L. Boyer,et al. Lnc ing Epigenetic Control of Transcription to Cardiovascular Development and Disease , 2015 .